Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
CanVeer Biopharma Inc. has filed an international Patent Cooperation Treaty (PCT) application for its lead investigational drug candidate AlveoShield™, marking a strategic step in securing global intellectual property rights. The filing supports CanVeer’s development of disease-modifying therapies for severe respirato…
Share This Article
Ready-to-post copy includes the article link.
CanVeer Biopharma Advances Global Patent Protection with PCT Filing for AlveoShield™ in Respiratory Disease Treatment CanVeer Biopharma Inc. has filed an international Patent Cooperation Treaty (PCT) application for its lead investigational drug candidate AlveoShield™, marking a strategic step in securing global intellectual property r... Read the full IIPLA article: https://iipla.org/news/canveer-biopharma-advances-global-patent-protection-with-pct-filing-for-alveoshield-in-respiratory-disease-treatment